What is "Industry 4.0" & Are We Ready for It?

About the Author

Senior Director, Strategic Partnerships & Past ISPE Board Chair

Pfizer Global Clinical Supplies

Michael A. Arnold is Senior Director of Strategic Partnerships and Investigational Products Business Process Owner for Pfizer's Global Clinical Supply Chain. In this capacity he...

Insights

Emerging Leaders Editorial: Personalized Medicine in the US

1 March 2024

Personalized medicine provides a treatment alternative that utilizes patients’ genetic material to produce therapeutics. According to Market Research Future, the US currently accounts for the largest share of the personalized medicine market, and it is expected to reach US $27.5 million by 2030.

Insights

Women in Pharma® Editorial: Women’s Participation in the Pharmaceutical Industry in Mexico

1 March 2024

Over time and with effort and determination, women in key leadership positions have proven that these positions are genderless for individuals with the correct set of abilities and knowledge.

Insights

Message from the Chair: A Regional Focus for 2024

1 March 2024

ISPE has started 2024 with great momentum, having two technical conferences in the first quarter, the 2024 ISPE Facilities of the Future Conference in San Francisco, California and the 2024 ISPE...

About the Author

Facilities of the Future: Meeting the Demands of Breakthrough Therapeutics

Emerging Leader Hacker to GAMPer in 10 Weeks

New Initiative Seeks to Back up ICHs Harmonization Mission

Data Science-Assisted Biopharmaceutical Tech Transfer and Process Characterization

Entering a New Era of Innovation and Collaboration With the Focus on the Workforce of the Future

Q&A with ISPE Foundation Professional Development Grant Recipient Silas Tamufor

Related Articles